What is the fair value of SRPT stock?

Our analysis estimates the fair value range for SRPT to be between $17.24 and $21.38. The current price is $20.45.

What is the analyst price target for SRPT?

The average Wall Street analyst price target for SRPT is $22.26. This implies a potential upside of 8.9% from current levels.

Sarepta Therapeutics (SRPT) Stock: Buy, Sell, or Hold?

SRPT - Sarepta Therapeutics,, Inc. Common Stock

PHARMACEUTICAL PREPARATIONS

$20.45

-0.07 (-0.34%) ▼

5d: -11.05%

30d: +11.26%

90d: +36.33%

WAIT

LOW Confidence

Protect Your SRPT Gains

Analysis Updated: Sep 11, 2026 12:00 AM ET

Earnings: Nov 02, 2026

Smart Money Accumulation

Options open interest is building while the stock consolidates - a pattern consistent with institutional accumulation. View Scanner →

Signal fired Sep 9, 2026 at $22.14 · last confirmed Sep 11, 2026

Strength: 6.1/10

Get Alerted When SRPT Hits Your Target Price

Join 10,000+ traders who never miss a move

You're in! Check your email to confirm and set your target price.

100% Free No spam, ever Unsubscribe anytime

Interactive Price Chart (1 Month)

Loading historical data...

💡

Bottom Line:
⏸️ WAIT FOR STABILIZATION: SRPT is down 11.0% over the last 5 days. While fundamentals may be solid, catching a falling knife is risky. Wait for price to stabilize before entering.

See Forward Earnings Fair Value & Price Prediction →

Long-Term Wealth Forecast (2031)

Based on Analyst Consensus Growth & Historical Valuation

Adjust Growth Assumption: -42.1%

0% (Stagnation) 50% (Hyper Growth)

EST. PRICE IN 2031

$5.47

Based on -19.1% avg growth

INTRINSIC VALUE TODAY

$3.39

Trading above historical range

How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 6.8x Exit PE.

View Full DCF Model

In-depth Analysis How we analyze

Valuation Analysis: SRPT is currently trading at $20.45, which is considered slightly high relative to its 30-day fair value range of $17.24 to $21.38. From a valuation perspective, the stock is trading at a premium (Forward PE: 8.0) compared to its historical average (6.8). At these levels, the market is pricing in 5.4% annual earnings growth. This growth rate appears achievable given the company's track record, suggesting the valuation is rational.

Technical Outlook: Technically, SRPT is in a strong downtrend. Immediate support is located at $19.51, while resistance sits at $23.62.

Market Sentiment: SRPT scores 15/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. Current signals suggest waiting for a better entry point before initiating new positions.

Quick Decision Summary

Current Position SLIGHTLY HIGH

Historical Trading Range $17.24 - $21.38

Company Quality Score 34/100 (SELL)

Volume Confirmation HIGH

Confidence Score 38.1%

Protect Your Profits

Holding SRPT? Use our AI-powered strategies to protect your downside while keeping your long-term position.

View Profit Protection Plan

All Signals

BEARISH: Weak technical setup (15/100)
BULLISH: High volume confirmation
NEUTRAL: Near Wall St target ($22.26)
NEUTRAL: PE elevated vs history but 5.4% growth expectation is conservative given 2664% recent growth
WARNING: Composite score 34/100 in the bottom quintile — this cohort historically lags the market

Trading Range Analysis

30-Day Trading Range $17.24 - $21.38

Current vs Trading Range SLIGHTLY HIGH

Support & Resistance Levels

Support Level $19.51

Resistance Level $23.62

Current Trend Strong Downtrend

Technical data as of Sep 11, 2026

Fundamental Context

Forward P/E (Next Year Est.) 7.96

Wall Street Target $22.26 (+8.9%)

Revenue Growth (YoY) -34.3%

Earnings Growth (YoY) 2663.8%

Profit Margin -6.9%

Valuation Premium vs History +5.4% premium

PE vs Historical 8.0 vs 6.8 STRETCHED

Market-Implied Price Targets If current PE multiple persists

Implied Growth (YoY): +5.4% (market-implied from PE analysis)

1-Year Target $21.55 (+5%)

2-Year Target $22.72 (+11%)

3-Year Target $23.95 (+17%)

3-Yr Target (if PE normalizes) (PE: 8→7) PE COMPRESSION $20.46 (0%)

Earnings growth offset by PE compression

3-Year Scenarios Using analyst projected EPS growth

Bull: (PE: 20.2, Growth: -42.1%) $37.78 (+85%)

Base: (SPY PE: 8.0, Growth: -42.1%) $14.91 (-27%)

Bear: (PE: 6.8, Growth: -42.1%) $12.67 (-38%)

Share & Embed Analysis

Found this analysis useful? Share it with your community or embed the live chart on your blog.

Tweet Reddit

bloggers & journalists: you are free to use our charts with attribution.

Last updated: September 11, 2026 8:34 PM ET
Data refreshes hourly during market hours. Next update: 9:34 PM

🔥 Top Stocks Breaking Out Now

Ticker	Score	Recommendation	Change %

See Full Scanner Results »

Technical Signals Check

Is SRPT showing a specific setup today?

RSI Divergence Check TTM Squeeze Check MACD Crossover Check Gamma Walls Check Unusual Activity Check

Insider Activity (6 Months)

Buys

Sells

Net

NEUTRAL

View Insider Activity Scanner

Unlock Insider Activity

See real-time buying/selling by company executives for SRPT.

Create Free Account

Already have an account? Log In

Top Rated Biotechnology Stocks

Top-rated stocks in Biotechnology by analyst ratings.

Stock	Analyst Consensus	Analyst Target	Tradestie Score
ALNY Alnylam Pharmaceuticals …	STRONG BUY 30 analysts	$370	43 HOLD
ONC BeiGene, Ltd.	STRONG BUY 24 analysts	$432	48 HOLD
VRTX Vertex Pharmaceuticals I…	BUY 34 analysts	$570	38 SELL
ACLX Arcellx Inc	STRONG BUY 18 analysts	$113	50 HOLD
ASND Ascendis Pharma AS	STRONG BUY 16 analysts	$315	47 HOLD

ALNY Alnylam Pharmaceu…

43 HOLD

ONC BeiGene, Ltd.

48 HOLD

VRTX Vertex Pharmaceut…

38 SELL

ACLX Arcellx Inc

50 HOLD

ASND Ascendis Pharma AS

47 HOLD

Advanced SRPT Option Strategies

Professional options setups generated by AI based on today's SRPT price and gamma walls.

Iron Condor Bull Call Bear Put Collar

More Analysis for SRPT

SRPT Technical Chart SRPT Price Prediction SRPT Earnings Date SRPT Investment Advisor SRPT Fair Price Analyzer SRPT Options Advisor SRPT Options Chain SRPT Options Analysis SRPT Competitors

Compare SRPT with Peers

SRPT vs ALNY
Which one to buy?

SRPT vs BMRN
Which one to buy?

SRPT vs ACAD
Which one to buy?

SRPT vs IONS
Which one to buy?

SRPT vs VRTX
Which one to buy?

VCEL vs SRPT
Winner: SRPT

SRPT vs AGIO

SRPT vs VRDN
Winner: SRPT

SRPT vs ALNY
Winner: ALNY

SRPT vs LQDA

SRPT vs IONS

Create New Comparison View All Competitors

Tradestie